No Detail Found!

Naion and anticoagulants: bridging the gap with rationale-based therapy

Author(s)
Syntia Nusanti Doctoral Program in Medical Science, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia and Neuro-ophthalmology Division, Ophthalmology Department
Andhika Rachman Hematology and Medical Oncology Division, University of Indonesia, Jakarta
Brigitta Marcia Budihardja Ophthalmology Department, Department of Internal Medicine, Faculty of Medicine University of Indonesia - Dr. Cipto Mangunkusumo Hospital,Jakarta-,Indonesia
Lourisa Ruth Eldinia Vitreoretina Division, Ophthalmology Department, Faculty of Medicine Padjajaran University – Cicendo Eye Hospital, Bandung-Indonesia
Nadia Delima Andini Neuro-ophthalmology Division, Ophthalmology Department, Faculty of Medicine University of Indonesia - Dr. Cipto Mangunkusumo Hospital, Jakarta-Indonesia
Arief Kartasasmita Vitreoretina Division, Ophthalmology Department, Faculty of Medicine Padjajaran University – Cicendo Eye Hospital, Bandung-Indonesia
M. Sidik Neuro-ophthalmology Division, Ophthalmology Department, Faculty of Medicine University of Indonesia - Dr. Cipto Mangunkusumo Hospital, Jakarta-Indonesia
Seskoati Prayitnaningsih Neuro-ophthalmology Division, Ophthalmology Department, Faculty of Medicine University of Indonesia - Dr. Cipto Mangunkusumo Hospital,Jakarta-,Indonesia
Alida Roswita Harahap Doctoral Program in Medical Science, Faculty of Medicine Universitas Indonesia, Jakarta-Indonesia
Aria Kekalih Community Medicine Department, Faculty of Medicine Universitas Indonesia, Jakarta-Indonesia
Tjahjono Darminto Gondhowiardjo Cataract and Refractive Surgery Division, Ophthalmology Department, Faculty of Medicine University of Indonesia - Dr. Cipto Mangunkusumo Hospital,Jakarta-,Indonesia
Abstract
Background: NAION, a multifactorial disorder with an unclear mechanism has limited insight on its treatment option. Despite conflicting results in its relation to hypercoagulation, many metabolic risk factors associated with NAION are intertwined with hypercoagulation. We aim to investigate the impact of anticoagulant therapy in the vascular and visual function of NAION patients. Methods: A prospective interventional study was conducted in the Neuro-Ophthalmology Division, Department of Ophthalmology at FKUI-RSCM Kirana from October 2020 to April 2022, involving two groups of NAION subjects: hypercoagulation and non-hypercoagulation. All subjects received 80 mg of aspirin daily, with the hypercoagulation group additionally receiving 2 mg of warfarin. We assessed capillary perfusion (CP) and flux index (FI) using OCTA, along with changes in visual acuity (Snellen chart test) and visual field (Humphrey Visual Field - HVF) at presentation and one month after treatment. Results: The hypercoagulation group had 14 subjects, while the nonhypercoagulation group had 7. This research found a significant decrease for CP (p=0.003) and FI (p=0.001) in both groups. CP and FI in all quadrants decreased more in the non-hypercoagulable group without anticoagulant therapy, although the difference between the two groups was not significant (p=0.198 for CP and p=0.243 for FI). Hypercoagulation group showed significant visual field improvements (p=0.033 for MD and p=0.014 for VFI). Most subjects within hypercoagulation showed improvement although not all of it was significant, while the majority of the nonhypercoagulation group showed no changes. Conclusion: Anticoagulant therapy could potentially mitigate the progression of flow insufficiency and facilitate clinical enhancement.
Publication Details
Page(s) 240-244
DOI DOI not available
Published Journal: Journal of Ayub Medical College, Volume: 36, Issue: 2, Year: 2024

Request the full text from PASTIC

Keywords
Thrombophilia, Visual acuity, Optical coherence tomography angiography, Visual field, anticoagulant, Non-arteritic anterior ischemic optic neuropathy
0

Citations

0

Downloads

47

Views